
Investigators have established a genomic outline of the CDK4/6i resistance in patients with breast cancer, growing the potential for novel treatments to circumvent that resistance.

Investigators have established a genomic outline of the CDK4/6i resistance in patients with breast cancer, growing the potential for novel treatments to circumvent that resistance.

Cyclin-dependent kinase 4/6 inhibitors offer the potential to significantly improve outcomes for women with HR-positive, HER2-negative breast cancer.

The study results also show improved outcomes for patients with brain metastases.

Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses suicidal ideation and behavior, and depression, as potential adverse effects of some medications.

Although CDK4/6 inhibitors prolong progression-free survival for patients with estrogen receptor-positive breast cancer, the ideal treatment for each patient is currently unclear until adverse effects appear.

The research presented at the 2019 San Antonio Breast Cancer Symposium suggests that the different mechanisms could be exploited to overcome CDK4/6 inhibitor resistance in breast cancer patients.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, discusses the role pharmacists play in the opioid crisis and pain management. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas.

Researchers say several key questions remain in the treatment of breast cancer: whether CDK4/6i therapy should be continued beyond progression, what the mechanisms of resistance are, and how agents should be selected.

"I think immunotherapy has certainly arrived for breast cancer," said Rita Nanda, MD.

Research presented at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas showed that patients who received focused attention from pharmacists during hospital stays expressed higher satisfaction.

The award is in recognition of members David F. Chen, senior director of the Section of Pharmacy Practice Leaders, and Verna L. Reed, director of Customer Relations and Materials Management for their exemplary work within the organization.

Emmy-award winning actress Julia Louis-Dreyfus brought the huge crowd to its feet Wednesday at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada, during a conversation with Caleb McEwen, artistic director of the Brave New Workshop comedy theater in Minneapolis, Minnesota.

Krutika Mediwala, PharmD, BCPS, explains current best practices for health systems in antimicrobial stewardship. This video was filmed at the 2019 ASHP 54th Midyear Clinical Meeting & Exhibition in Las Vegas.

Patricia Spears discusses what clinical trials can offer and when to start discussing them with patients. This video was filmed December 11 at the 2019 San Antonio Breast Cancer Symposium.

Tom Kraus, vice president, government affairs for the American Society of Health-System Pharmacists (ASHP) discusses legislators' top concerns with drug pricing and what they're doing to solve the problem. This video was filmed at the ASHP 54th Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.

The consumption of these antibiotics may lead to dangerous unintended consequences, such as adverse effects that include treatment failures, and antibiotic drug resistance.

Volunteer leaders recognized for advancing mission of sections, new practitioners forum.

Danny Sanchez, VP and general manager of population health services for Omnicell, discusses how technology is bringing pharmacists closer to their patients. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas.

Immunotherapy drug blinatumomab showed benefit in pediatric patients with relapsed acute lymphoblastic leukemia who have minimal residual disease following chemotherapy.

A combination therapy of carfilzomib, dexamethasone, and daratumumab extended progression-free survival when compared with carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.

An oral formulation of azacitidine improved overall survival in patients with acute myeloid leukemia in first remission.

In addition to handling issues such as depression, post-traumatic stress disorder, suicide screenings, and anxiety, many mental health pharmacists deal with typical metabolic conditions, such as hypertension and diabetes.

Lisa Dumkow, PharmD, BCIDP, a clinical pharmacist of antimicrobial stewardship, discusses outpatient stewardship and why it's vital for health system pharmacists. This video was filmed at the 2019 ASHP Midyear Meeting Clinical Meeting & Exhibition in Las Vegas.

Tim Ulbrich, PharmD and CEO of Your Financial Pharmacist, discusses his top tips for pharmacists with student loans. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.

The current observational, longitudinal study focused on patient-reported outcomes on functioning, symptoms, and quality of life in patients with chronic lymphocytic leukemia.

Four healthcare practitioners have been recognized by the American Society of Health-System Pharmacists (ASHP) with different leadership awards. The honorees were presented with the awards during specific ceremonies at the ASHP Midyear Clinical Meeting and Exhibition in Las Vegas.

A pharmacy-driven assessment found more than half of patients with reported penicillin allergies were able to take antibiotics from the same drug class, rather than resorting to substitutes that may have downsides.

Check the Pharmacy Times® website for more information and be sure to watch for daily newsletters, online conference articles and videos, and social media updates.

A poster presented at the American Society of Hematology Annual Meeting and Exposition assessed disease-related health care utilization and costs among patients with multiple myeloma.

The award recognizes pharmacists who demonstrate leadership and innovation in enhancing patient care and other areas of pharmacy practice.